Company news

Pegbio Co., Ltd. Class H (HKEX:2565) news

Pegbio Co., Ltd. Class H news releases on 6ix. Latest, Jun 29, 2026: VOLUNTARY ANNOUNCEMENT CORE PRODUCT VISEPEGENATIDE INJECTION PASSED THE PRELIMINARY…

View Pegbio Co., Ltd. Class H →

Press releases & updates

VOLUNTARY ANNOUNCEMENT CORE PRODUCT VISEPEGENATIDE INJECTION PASSED THE PRELIMINARY REVIEW IN ACCORDANCE WITH THE 2026 NATIONAL REIMBURSEMENT DRUG LIST ADJUSTMENT

June 29, 2026

Next Day Disclosure Return

June 26, 2026

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

June 24, 2026